Last reviewed · How we verify
NCT06003985
Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists
trial testing Gastric Ultrasound Exam in Gastric Ultrasound in 354 participants. Completed in 1 February 2025.
31 January 2025
Quick facts
| Lead sponsor | Hospital for Special Surgery, New York |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 354 |
| Start date | 29 August 2023 |
| Primary completion | 31 January 2025 |
| Estimated completion | 1 February 2025 |
| Sites | 8 locations across Canada, United States |
Drugs / interventions tested
- Gastric Ultrasound Exam
Conditions studied
- Gastric Ultrasound — all drugs for Gastric Ultrasound →
- Glucagon-like Peptide 1 — all drugs for Glucagon-like Peptide 1 →
- Point of Care Ultrasound — all drugs for Point of Care Ultrasound →
Sponsor
Hospital for Special Surgery, New York
Who can join
Adults 18 to 99, any sex, with Gastric Ultrasound or Glucagon-like Peptide 1. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to perform bedside gastric point of care ultrasound (POCUS) exams to assess the gastric volume and content (clear liquids vs solid food) perioperatively in patients who take glucagon-like peptide 1 (GLP-1) agonist medications compared to patients who do not take GLP-1 agonists.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06003985
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Gastric Ultrasound Exam
Trials testing the same drug.
- NCT06567873 — Gastric Ultrasound Assessment for Patients Taking Cannabis · completed
Other recruiting trials for Gastric Ultrasound
Currently open trials in the same condition.
- NCT07352202 — Ultrasound Assessment of Gastric Emptying in Mechanically Ventilated ICU Patients · recruiting
- NCT06600035 — Gastric Ultrasound in Elective Surgical Diabetic Patients · recruiting
- NCT07032207 — Correlation of Preoperative Gastric Residual Volume With Body Mass Index and Aspiration Risk in Laparoscopic Bariatric S · recruiting
- NCT06620549 — Feasibility of Nurse-performed Gastric Ultrasound After Surgery · recruiting
- NCT06643325 — Gastric Emptying Time in Traumatic Injuries · recruiting
Other Hospital for Special Surgery, New York trials
Trials by the same sponsor.
- NCT07226700 — Suzetrigine in Total Hip Arthroplasty · Phase 3 · recruiting
- NCT06567873 — Gastric Ultrasound Assessment for Patients Taking Cannabis · completed
- NCT07217964 — Natural Matrix Protein · enrolling by invitation
- NCT06798493 — CSS-SR Validation Study · enrolling by invitation
- NCT06180486 — Mindfulness Meditation Intervention Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06003985 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital for Special Surgery, New York
- Last refreshed: 26 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06003985.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing